In fact, CD200 is known to act as an immunosuppressive molecule that is upregulated on primary CLL B-cells (18). Moreover, an elegant work by Kretz-Rommel and co-workers demonstrated that CD200 expression by tumor cells suppresses antitumor responses in an animal model (22). This evidence concerns the gene CD200 and neoplasm.